000			01933 a2200529 4500
005			20250517205907.0
264		0	_c20180827
008			201808s 0 0 eng d
022			_a1179-1985
024	7		_a10.1007/s40292-018-0256-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aIannaccone, Andrea
245	0	0	_aEvaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma Therapy. _h[electronic resource]
260			_bHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension _cJun 2018
300			_a209-218 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aAsymptomatic Diseases
650	0	4	_aBortezomib _xadverse effects
650	0	4	_aCardiotoxicity
650	0	4	_aCase-Control Studies
650	0	4	_aEchocardiography, Doppler
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Myeloma _xdiagnosis
650	0	4	_aOligopeptides _xadverse effects
650	0	4	_aProteasome Endopeptidase Complex _xdrug effects
650	0	4	_aProteasome Inhibitors _xadverse effects
650	0	4	_aRisk Factors
650	0	4	_aTreatment Outcome
650	0	4	_aVentricular Dysfunction, Left _xchemically induced
650	0	4	_aVentricular Function, Left _xdrug effects
700	1		_aBruno, G
700	1		_aRavera, A
700	1		_aGay, F
700	1		_aSalvini, M
700	1		_aBringhen, S
700	1		_aSabia, L
700	1		_aAvenatti, E
700	1		_aVeglio, F
700	1		_aMilan, A
773	0		_tHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension _gvol. 25 _gno. 2 _gp. 209-218
856	4	0	_uhttps://doi.org/10.1007/s40292-018-0256-1 _zAvailable from publisher's website
999			_c28221217 _d28221217